7th Annual ECD Medical Symposium Milan, Italy

Xavier Solanich, MD, PHD
IRCCS San Raffaele Scientific Institute
Milan, Italy
April 1, 2019

Milan Medical Symposium Group Picture 2019

Symposium Summary

Approximately 38 medical professionals from nine countries attended the Annual ECD Medical Symposium in 2019. Twelve oral abstracts were presented, along with an additional four poster presentations. As an invited speaker, Prof. Luigi Naldini, delivered a talk titled “Genetic engineering of hematopoiesis to treat

inherited diseases and cancer.” An evening reception provided time for discussions supporting current and future collaborations among this highly knowledgeable group of physicians and scientists, all interested in learning more about Erdheim-Chester Disease.

Attendee Experiences

“ECDGA provides important resources for my patients that has led to faster diagnosis. It also provides a community for patients with a rare disease to feel less alone.”

– Mark Heaney, MD, 2019 Attendee

Programs with Symposium Agenda

Presentations

PresenterPresentation Slides
Jithma P. Abeykoon, MDHistopathologic Mimics of Erdheim-Chester Disease (ECD)
Benjamin H. DurhamNovel Alterations in CSF1R, RET, and Other Diverse Kinases in the Histiocytoses with Biochemical and Structural Insights into Their Mechanisms of Activation
Marina Ferrarini, MD3D culture of BRAF/KRAS-mutated Erdheim-Chester disease tissues unveils rewired histiocyte metabolism as new therapeutic target
Filip Janku, MD, PhDMEK inhibition with trametinib in patients with non-Langerhans cell histiocytosis irrespective of BRAF mutation status
Francesco Pegoraro, MDErdheim-Chester with multiple lesions related to BRAF V600E mutation. A simple coincidence?

Photographs

Reception